IRF2BP2 anticorps (C-Term)
Aperçu rapide pour IRF2BP2 anticorps (C-Term) (ABIN1450118)
Antigène
Voir toutes IRF2BP2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, Mouse.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 18 amino acid synthetic peptide near the carboxy terminus of Human IRF2BP2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- IRF2BP2 (Interferon Regulatory Factor 2 Binding Protein 2 (IRF2BP2))
-
Autre désignation
- IRF2BP2
-
Sujet
- IRF2BP2, like the related protein IRF2BP1, is a co-repressor that interacts specifically with the C-terminal repression domain of Interferon Regulatory Factor 2 (IRF2). IRF2BP2 is a direct target gene of p53 and is involved in cell survival during the p53 stress response, able to impede the p53-mediated transactivation of p21 and Bax. IRF2BP2 is also a co-factor of VGLL4 and is required to induce the expression of vascular endothelial growth factor A (VEGF-A) in muscle. It is normally found in the nucleus of skeletal muscle and cardiac cells, but can be found in the cytoplasm during skeletal muscle differentiation.Synonyms: IRF-2-binding protein 2, IRF-2BP2, Interferon regulatory factor 2-binding protein 2
-
ID gène
- 359948
-
NCBI Accession
- NP_892017
Antigène
-